3.2. Synthesis of Ligands (L1–L5)
L1. To a mixture of 2-(2,6-bis(4,4′-difluorobenzhydryl)-4-trifluoromethoxy) acenaphthylen-1-one (1.49 g, 2.0 mmol), 2,6-dimethylaniline (0.36 g, 3.0 mmol), and a catalytic amount of p-toluenesulfonic acid (0.37 g), toluene (30 mL) was added. The resulting solution was refluxed for 6 h. After the reaction, all volatiles were removed under reduced pressure, and the residue was purified by alumina column chromatography (500/8 petroleum ether/ethyl acetate). The product was obtained as a yellow powder (0.49 g, 27.6%). 1H NMR (400 MHz, CDCl3, TMS): δ 7.82 (d, J = 8.4 Hz, 1H, An-H), 7.75 (d, J = 8.0 Hz, 1H, An-H), 7.33 (t, J = 7.6 Hz, 1H, An-H), 7.19 (d, J = 7.6 Hz, 2H, Ar-H), 7.13–7.09 (m, 1H, Ar-H), 7.06 (t, J = 7.6 Hz, 1H, An-H), 7.02–6.94 (m, 8H, Ar-H), 6.87–6.82 (m, 6H, Ar-H), 6.59 (d, J = 7.2 Hz, 1H, An-H), 6.32 (t, J = 8.4 Hz, 1H, Ar-H), 5.98 (d, J = 7.2 Hz, 1H, An-H), 5.59 (s, 2H, -CHPh2), 2.19 (s, 6H, -CH3). 13C NMR (100MHz, CDCl3, TMS): δ 164.2, 162.9, 162.0, 161.1, 160.4, 159.6, 148.8, 147.4, 145.4, 139.9, 137.5, 137.5, 136.5, 136.5, 134.2, 131.1, 131.0, 130.7, 130.6, 130.1, 129.3, 129.2, 128.5, 128.3, 128.1, 127.9, 126.7, 124.5, 124.1, 123.6, 122.4, 121.8, 120.9, 119.2, 115.4, 115.2, 115.1, 114.9, 50.9, 50.6, 18.1. 19F NMR (470 MHz, CDCl3, TMS): δ −58.17, −116.12, −116.35. FT-IR (cm−1): 3074 (w), 3043 (w), 2977 (w), 2941 (w), 1662 (m, vC = N), 1635 (w, vC = N), 1697 (m), 1506 (s), 1465 (w), 1440 (m), 1257 (w), 1217 (w), 1159 (w), 1095 (w), 1040 (w), 1012 (w), 928 (w), 875 (w), 828 (m), 802 (w), 769 (m). Anal. calcd for C53H35F7N2O·H2O (848.86): C, 74.99; H, 4.16; N, 3.30. Found: C, 75.24; H, 4.10; N, 3.11%.
L2. Using a typical procedure as described for the synthesis of L1, L2 was prepared as a yellow powder (0.51 g, 29.1%). 1H NMR (400 MHz, CDCl3, TMS): δ 7.80 (d, J = 8.0 Hz, 1H), 7.71 (d, J = 8.4 Hz, 1H), 7.31 (t, J = 7.8 Hz, 1H), 7.25–7.20 (m, 3H), 7.02–6.94 (m, 9H), 6.86–6.83 (m, 6H), 6.58 (d, J = 7.2 Hz, 1H), 6.30 (t, J = 8.6 Hz, 4H), 5.88 (d, J = 7.2 Hz, 1H), 5.60 (s, 2H), 2.70–2.61 (m, 2H), 2.54–2.45 (m, 2H), 1.17 (t, J = 7.4 Hz, 6H). 13C NMR (100MHz, CDCl3, TMS): δ 162.9, 162.0, 161.2, 160.4, 159.6, 147.9, 147.5, 139.9, 137.8, 136.5, 136.4, 134.2, 131.0, 130.7, 130.6, 130.4, 130.00, 129.2, 129.0, 128.3, 127.8, 126.6, 126.4, 124.5, 123.7, 122.9, 121.0, 115.4, 115.2, 115.1, 114, 9, 50.6, 24.5, 14.4. 19F NMR (470 MHz, CDCl3, TMS): δ −58.18, −116.13, −116.33. FT-IR (cm−1): 3053 (w), 2966 (w), 2937 (w), 2878 (w), 1672 (w, vC = N), 1654 (w, vC = N), 1598 (w), 1506 (s), 1437 (m), 1253 (w), 1224 (w), 1159 (w), 1095 (w), 1042 (w), 1014 (w), 923 (w), 875 (w), 828 (w), 802(w), 782 (w). Anal. calcd for C55H39F7N2O·H2O (876.92): C, 75.33; H, 4.48; N, 3.19. Found: C, 75.65; H, 4.32; N, 2.87%.
L3. Using a typical procedure as described for the synthesis of L1, L3 was prepared as a yellow powder (0.44 g, 24.1%). 1H NMR (400 MHz, CDCl3, TMS): δ 7.78 (d, J = 8.4 Hz, 1H), 7.68 (d, J = 8.4 Hz, 1H), 7.33–7.29 (m, 4H, An-H), 7.02–6.93 (m, 9H), 6.85–6.82 (m, 6H), 6.48 (d, J = 7.2 Hz, 1H), 6.27 (t, J = 8.6 Hz, 4H), 5.79 (d, J = 7.2 Hz, 1H), 5.61 (s, 2H), 3.14–3.04 (m, 2H), 1.29 (d, J = 6.8 Hz, 6H), 1.01 (d, J = 6.8 Hz, 6H). 13C NMR (100MHz, CDCl3, TMS): δ 164.4, 162.9, 162.0, 161.8, 160.4, 159.6, 147.6, 146.7, 145.5, 139.9, 137.9, 136.4, 135.4, 134.3, 131.0, 130.8, 130.7, 130.0, 129.3, 128.9, 128.2, 127.7, 127.5, 126.6, 124.9, 123.8, 123.4, 121.1, 115.4, 115.2, 115.0, 50.6, 28.7, 24.2, 23.7. 19F NMR (470 MHz, CDCl3, TMS): δ −58.19, −116.12, −116.28. FT-IR (cm−1): 3053 (w), 2965 (w), 2932 (w), 2876 (w), 1671 (w, vC = N), 1649 (w, vC = N), 1598 (w), 1506 (s), 1436 (w), 1392 (w), 1361 (w), 1333 (w), 1300 (w), 1228 (w), 1165 (w), 1095 (w), 1041 (w), 1014 (w), 923 (w), 876 (w), 830 (m), 785 (w), 761 (w). Anal. calcd for C57H43F7N2O·H2O (904.97): C, 75.65; H, 4.79; N, 3.10. Found: C, 75.37; H, 5.06; N, 3.44%.
L4. Using a typical procedure as described for the synthesis of L1, L4 was prepared as a yellow powder (0.66 g, 38.0%). 1H NMR (400 MHz, CDCl3, TMS): δ 7.81 (d, J = 8.0 Hz, 1H), 7.74 (d, J = 8.4 Hz, 1H), 7.34 (t, J = 7.8 Hz, 1H), 7.07–6.93 (m, 11H), 6.86–6.82 (m, 6H), 6.66 (d, J = 7.2 Hz, 1H), 6.32 (t, J = 8.6 Hz, 4H), 5.98 (d, J = 6.8 Hz, 1H), 5.58 (s, 2H), 2.39 (s, 3H), 2.15 (s, 6H). 13C NMR (100MHz, CDCl3, TMS): δ 164.2, 162.9, 162.1, 161.2, 160.5, 159.6, 147.5, 146.4, 145.4, 139.9, 137.6, 136.6, 134.2, 133.4, 131.1, 131.0, 130.8, 130.7, 130.1, 129.2, 128.5, 128.1, 126.6, 124.3, 123.5, 122.4, 121.8, 120.9, 119.3, 115.4, 115.2, 115.1, 114.9, 50.9, 50.7, 20.9, 18.0. 19F NMR (470 MHz, CDCl3, TMS): δ −58.17, −116.16, −116.39. FT-IR (cm−1): 3043 (w), 2975 (w), 2912 (w), 1668 (w, vC = N), 1642 (w, vC = N), 1599 (w), 1506 (m), 1482 (w), 1440 (w), 1256 (w), 1224 (w), 1155 (w), 1096 (w), 1035 (w), 1013 (w), 925 (w), 831 (m), 778 (m), 732 (w). Anal. calcd for C54H37F7N2O·H2O (862.89): C, 75.17; H, 4.32; N, 3.25. Found: C, 75.56; H, 4.73; N, 3.09%.
L5. Using a typical procedure as described for the synthesis of L1, L5 was prepared as a yellow powder (0.40 g, 22.5%). 1H NMR (400 MHz, CDCl3, TMS): δ 7.79 (d, J = 8.4 Hz, 1H), 7.70 (d, J = 8.4 Hz, 1H), 7.32 (t, J = 7.6 Hz, 1H), 7.04 (s, 2H), 7.02–6.94 (m, 9H), 6.86–6.82 (m, 6H), 6.64 (d, J = 7.2 Hz, 1H), 6.30 (t, J = 8.4 Hz, 4H), 5.87 (d, J = 7.2 Hz, 1H), 5.60 (s, 2H), 2.65–2.56 (m, 2H), 2.51–2.42 (m, 5H), 1.14 (t, J = 7.4 Hz, 6H). 13C NMR (100MHz, CDCl3, TMS): δ 164.2, 162.9, 162.1, 161.2, 160.4, 159.6, 147.5, 146.3, 145.4, 139.9, 137.6, 136.6, 134.2, 133.4, 131.1, 131.0, 130.7, 130.6, 130.1, 129.2, 129.1, 128.4, 128.0, 126.6, 124.3, 123.5, 122.4, 121.0, 115.4, 115.2, 115.0, 114.8, 50.8, 50.6, 20.9,18.0. 19F NMR (470 MHz, CDCl3, TMS): δ −58.18, −116.17, −116.38. FT-IR (cm−1): 3048 (w), 2965 (w), 2918 (w), 2854 (w), 1661 (w, vC = N), 1640 (w, vC = N), 1598 (w), 1505 (m), 1463 (w), 1438 (w), 1256 (w), 1217 (w), 1152 (w), 1093 (w), 1042 (w), 1013 (w), 927 (w), 864 (w), 829 (w), 786 (w). Anal. calcd for C56H41F7N2O·H2O (890.95): C, 75.49; H, 4.64; N, 3.14. Found: C, 75.12; H, 4.26; N, 3.54%.
3.3. Synthesis of Nickel Complexes (Ni1–Ni5)
Ni1. Under a nitrogen atmosphere, L1 (0.10 g, 0.12 mmol), NiBr2(DME) (0.04 g, 0.12 mmol), dichloromethane (6 mL), and ethanol (4 mL) were stirred at ambient temperature for 12 h. The solution was concentrated, and diethyl ether (25 mL) was added to precipitate the product. It was collected by filtration and washed with excess diethyl ether (3 × 15 mL) affording Ni1 as a red powder (0.12 g, 92.1% yield). 1H NMR (400 MHz, CD2Cl2, TMS): δ 28.48 (s, 6H, −CH3), 25.39 (s, 2H, Ar-Hm), 25.06 (s, 1H, An-H), 21.81 (s, 2H, Ar-Hm), 18.74 (s, 1H, An-H), 16.90 (s, 1H, An-H), 16.06 (s, 1H, An-H), 11.91 (broad, 0.81H, −CHPh2F2), 8.16 (s, 4H, Ar-H), 7.07 (s, 4H, Ar-H), 6.31 (s, 1H, An-H), 5.46 (s, 4H, Ar-H), 5.05 (s, 1H, An-H), 1.25 (s, 4H, Ar-H), -16.17 (s, 1H, Ar-Hp). 19F NMR (470 MHz, CDCl3, TMS): δ −57.12, −115.73, −116.07. FT-IR (cm−1): 3071 (w), 3036 (w), 2972 (w), 2906 (w), 1649 (w, vC = N), 1623 (w, vC = N), 1601 (w), 1585 (w), 1506 (s), 1444 (w), 1421 (w), 1262 (w), 1221 (w), 1158 (m), 1096 (w), 1051 (w), 1014 (w), 959 (w), 878 (w), 834 (m), 773 (m). Anal. calcd for C53H35Br2F7N2NiO (1067.37): C, 59.64; H, 3.31; N, 2.62. Found: C, 60.01; H, 3.17; N, 2.35%.
Ni2. Using a typical procedure as described for the synthesis of Ni1, Ni2 was also afforded as a red powder (0.11 g, 86.2% yield). 1H NMR (400 MHz, CDCl3, TMS): δ 28.89 (s, 2H, −CH2CH3), 27.44 (s, 2H, −CH2CH3), 25.69 (s, 1H, An-H), 25.51 (s, 2H, Ar-Hm), 22.31 (s, 2H, Ar-Hm), 19.48 (s, 1H, An-H), 17.36 (s, 1H, An-H), 16.52 (s, 1H, An-H), 13.21 (broad, 1.2H, −CHPh2F2), 8.20 (s, 4H, Ar-H), 7.07 (s, 4H, Ar-H), 6.09 (s, 1H, An-H), 5.54 (s, 4H, Ar-H), 4.97 (s, 1H, An-H), 1.79 (s, 2H, Ar-H), 1.22 (s, 1H, Ar-H), 0.81 (s, 7H, Ar-H, −CH2CH3), −16.87 (s, 1H, Ar-Hp). 19F NMR (470 MHz, CDCl3, TMS): δ −57.09, −115.67, −116.16. FT-IR (cm−1): 3069 (w), 3046 (w), 2978 (w), 2942 (w), 1649 (w, vC = N), 1621 (w, vC = N), 1603 (w), 1583 (w), 1505 (s), 1440 (w), 1421 (w), 1293 (w), 1256 (w), 1217 (w), 1157 (w), 1104 (w), 1050 (w), 1014 (w), 958 (w), 877 (w), 831 (m), 771 (w), 729 (w). Anal. calcd for C55H39Br2F7N2NiO (1095.42): C, 60.31; H, 3.59; N, 2.56. Found: C, 60.11; H, 3.46; N, 2.78%.
Ni3. Using a typical procedure as described for the synthesis of Ni1, Ni3 was also afforded as a red powder (0.11 g, 84.9% yield). 1H NMR (400 MHz, CDCl3, TMS): δ 26.25 (s, 1H, An-H), 25.16 (s, 2H, Ar-Hm), 22.75 (s, 2H, Ar-Hm), 2.10 (s, 1H, An-H), 17.89 (s, 1H, An-H), 16.72 (s, 1H, An-H), 13.80 (broad, 2H, −CHPh2F2), 8.14 (s, 4H, Ar-H), 7.02 (s, 4H, Ar-H), 6.85 (s, 1H, An-H), 5.68 (s, 6H, Ar-H), 4.97 (s, 1H, An-H), 1.87 (s, 7H, Ar-H, −CH(CH3)2), 1.69 (s, 6H, −CH(CH3)2), 1.30 (s, 1H, Ar-H), 1.03 (s, 2H, −CH(CH3)2), −16.41 (s, 1H, Ar-Hp). 19F NMR (470 MHz, CDCl3, TMS): δ −57.19, −115.91, −116.09. FT-IR (cm−1): 3072 (w), 3038 (w), 2969 (w), 2913 (w), 1645 (w, vC = N), 1620 (w, vC = N), 1601 (w), 1582 (w), 1506 (s), 1442 (w), 1421 (w), 1390 (w), 1364 (w), 1328 (w), 1298 (w), 1261 (w), 1220 (w), 1159 (w), 1097 (w), 1050 (w), 1014 (w), 958 (w), 876 (w), 832 (m), 772 (w), 734 (w). Anal. calcd for C57H43Br2F7N2NiO (1123.47): C, 60.94; H, 3.86; N, 2.49. Found: C, 60.73; H, 3.52; N, 2.57%.
Ni4. Using a typical procedure as described for the synthesis of Ni1, Ni4 was also afforded as a red powder (0.11 g, 87.8% yield). 1H NMR (400 MHz, CDCl3, TMS): δ 34.47 (s, 3H, Ar–p–CH3), 29.31 (s, 6H, -CH3), 25.92 (s, 1H, An-H), 25.31 (s, 2H, Ar-Hm), 22.07 (s, 2H, Ar-Hm), 19.14 (s, 1H, An-H), 17.23 (s, 1H, An-H), 16.40 (s, 1H, An-H), 12.71 (broad, 0.99H, −CHPh2F2), 8.18 (s, 4H, Ar-H), 7.07 (s, 4H, Ar-H), 6.20 (s, 1H, An-H), 5.47 (s, 4H, Ar-H), 4.92 (s, 1H, An-H), 1.26 (s, 2H, Ar-H), 1.07 (s, 2H, Ar-H). 19F NMR (470 MHz, CDCl3, TMS): δ −57.15, −115.78, −116.10. FT-IR (cm−1): 3069 (w), 2991 (w), 2911 (w), 1643 (w, vC = N), 1624 (w, vC = N), 1602 (w), 1583 (w), 1505 (s), 1443 (w), 1269 (m), 1217 (m), 1191 (w), 1155 (m), 1096 (w), 1048 (w), 1015 (w), 962 (w), 877 (w), 832 (m), 777 (w). Anal. calcd for C54H37Br2F7N2NiO (1081.39): C, 59.98; H, 3.45; N, 2.59. Found: C, 60.26; H, 3.58; N, 2.27%.
Ni5. Using a typical procedure as described for the synthesis of Ni1, Ni5 was also afforded as a red powder (0.12 g, 90.5% yield). 1H NMR (400 MHz, CDCl3, TMS): δ 34.75 (s, 3H, Ar–p–CH3), 28.61 (s, 2H, −CH2CH3), 27.53 (s, 2H, −CH2CH3), 26.25 (s, 1H, An-H), 25.19 (s, 2H, Ar-Hm), 22.29 (s, 2H, Ar-Hm), 19.29 (s, 1H, An-H), 17.30 (s, 1H, An-H), 16.54 (s, 1H, An-H), 13.02 (broad, 1.2H, −CHPh2F2), 8.24 (s, 4H, Ar-H), 7.08 (s, 4H, Ar-H), 6.16 (s, 1H, An-H), 5.53 (s, 4H, Ar-H), 4.90 (s, 1H, An-H), 1.22 (s, 3H, Ar-H), 0.87 (s, 7H, Ar-H, −CH2CH3). 19F NMR (470 MHz, CDCl3, TMS): δ −58.16, −115.86, −116.09. FT-IR (cm−1): 3079 (w), 2975 (w), 2935 (w), 2873 (w), 1644 (w, vC = N), 1618 (w, vC = N), 1602 (w), 1583 (w), 1504 (s), 1444 (w), 1383 (w), 1296 (w), 1252 (w), 1220 (w), 1174 (w), 1157 (w), 1098 (w), 1054 (w), 1015 (w), 960 (w), 868 (w), 831 (m), 773 (m), 731 (w). Anal. calcd for C56H41Br2F7N2NiO (1109.45): C, 60.63; H, 3.73; N, 2.53. Found: C, 60.48; H, 3.61; N, 2.88%.